Therefore, the APN-mediated regulation of BCKDK activity in liver cancer may be related to its abnormal enzyme activity affecting BCAA catabolism homeostasis, and we plan to investigate this hypothesis in the future. This evidence concerns the gene BCKDK and liver cancer.